TP53 and breast cancer: Finally, to the best of our knowledge, this is the first study to investigate endogenous levels of p53 isoform protein expression in a breast cancer cohort, and as shown in this study, the use of a suite of specific antibodies may provide detailed analyses, making the investigation of p53 isoforms via IHC possible.